Pliant Therapeutics Inc. said it saw positive interim results from a Phase 2a positron emission tomography imaging-based clinical trial of PLN-74809 in patients with idiopathic pulmonary fib..查看文章
Pliant Therapeutics Inc. (NASDAQ:PLRX) traded at $19.16 at close of the session on Tuesday, September 07, made a downward move of -0.83% on its previous day’s price. Looking at the stock we..查看文章
Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced that..查看文章
Pliant Therapeutics Inc. (NASDAQ:PLRX) has seen 1.07 million shares traded in the recent trading session. The company, currently valued at $699.77M, closed the recent trade at $21.17 per sha..查看文章
Pliant Therapeutics reported positive data from a phase 2 trial with its experimental fibrosis therapy, PLN-74809, this morning. Data from four patients given the anti-fibrosis candidate sug..查看文章
pliant与发音含义,同义词,反义词,翻译,刑和更多的